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Abstract 
We have analyzed the a 2//~ I-, ~ / [~- ,  ~/(~ + ~)-mRNA ratios in the retic-ulocytes of 40 patients with Hb H disease. 21 patients had 
deletional Hb H disease ( - - / - a), namely combinations of one of four types of a-thal-I (MED-I, MED-II, -(a)20.5, SEA) and one 
of two types of or-thai-2 ( -  3.7 or -4.2 kb); 13 had Hb H disease because of combinations of one of these a-thal-1 deletions with either 
a 5 nt deletion at the 5' splicing site of IVS-I, or a terminating codon mutation (Hb CS), or a poly(A) mutation, and six were homozygous 
for either a poly(A) mutation or the 5 nt deletion. Significant differences were observed between the deletional types ( - - / - c~; c~ 2/c~t 
ratio of zero; ~/~3 ratio of ~ 1) and non-deletional types ( -  -/c~rc~; C%/C~ ratio of 0.05-0.3 for those with T = the 5 nt deletion or 
the terminating codon mutant, and ~ 1.0 for those with T = a poly(A) mutation; c~/[3 ratio in all types of ~ 0.7). Comparable data were 
found for the nondeletional c~-thal-2 homozygotes. The noted differences were highly significant and the determination f the two ratios 
may be diagnostically of considerable value. The low c~ 2/a ~-mRNA ratio in the two patients with - -/c~-5"tc~ and the one patient with 
a-5nta/e~-5"te~ indicates the presence of minute amounts of c~ 2-mRNA; apparently splicing at the donor site is greatly impaired by this 
deletion but not eliminated. The high a2 /a  rmRNA ratio in the four patients with - -/aPA-2c~ and the five patients with ~xPA-la/ 
aPA-%~ (PA-1 and PA-2 are poly(A) mutations) is due to the presence of an elongated a2-mRNA which uses an alternate location as 
polyadenylation site. The relative levels of ~-mRNA varied considerably; the highest levels were found in patients with the - (a )20 .5 / -a  
or - -SEA/_  a deletional types but not in those with the -(c020.5/aPA-2a, --(oD20.5/a-5nta, or -- --SEA/c~CSc~ nondeletional types. 
No definitive xplanation can be given for these differences; perhaps certain sequences that are part of some of the ~t-thal-I deletions are 
important for the suppression of the ~-globin gene. 
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1. Introduction 
Hb H disease is a moderately severe hemolytic anemia 
that results from a significant decrease in the synthesis of 
a-chains, thus preventing adequate production of normal 
Hb A (a2132) and Hb A 2 (cx282) in the adult patient and 
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of fetal hemoglobin or Hb F (a2'~2) in the fetus and 
newborn baby. The excess 13- and ",/-chains form tetramers 
of 13-chains in the adult (Hb H or 13 4) and of "v-chains in 
the newborn (Hb Bart's or "/4). Loss of a-chain production 
is most often caused by genetic abnormalities involving 
one or both genes directing the synthesis of a-chains. 
These oL genes are located on the short arm of chromo- 
some # 16 in the order: Telomere-~-0~ 1-0a 2-t~a j-a j-a 2- 
01-centomere [1]. Three of the listed genes (42, a 2, a l) 
are functional genes, three are pseudo genes ( t~ l ,  t~a2, 
t~al), while the function of the 01 gene is unknown and a 
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01-chain has not been detected. Reciprocal recombination 
between specific homologous subsegments produces a 
chromosome with only one a-globin gene (-e~ -37 kb; 
rightward eletion), while a similar mechanism between a 
second set of homologous ubsegments also results in a 
chromosome with one e~-globin gene but characterized by 
a deletion of 4.2 kb ( -  ~x -42 kb; leftward deletion). These 
two conditions are known as et-thalassemia-2 (c~-thal-2) or 
( -c~/acx).  In addition, there are numerous deletions de- 
scribed in which both et-globin genes are completely or 
partially absent; chromosomes with such a deletion will 
direct no a-chain synthesis (eL-thal-I or - -/e~cx). 
Hb H disease most frequently results from the interac- 
tion of an a-thal-2 ( - c~/ )  determinant and an a-thal-1 
( - - / )  determinant; hus, a subject with this condition 
carries only one functional a-globin gene ( - - / -o r ) .  
This type of Hb H disease is most commonly found in 
Southeast Asia and in Mediterranean countries. Several 
nondeletional or-thai determinants have also been discov- 
ered (reviewed in Ref. [1]). These concern mutations or 
frameshifts primarily in the e~2-globin gene and some in 
the c~ x-globin gene, rendering such a gene nonfunctional 
(oLTe~ or e~c~l'). Hb H disease may therefore also result 
from the co-inheritance of a nondeletional e~-thal and a 
deletional a-thal-I (c~Te~/- -- ) or even of two nondele- 
tional c~-thal alleles (o~To~/c~Te~). Thus, the genetic basis of 
Hb H disease differs resulting in a considerable variability 
in clinical severity, which in turn correlates with the 
degree of c~-chain deficiency. 
Reverse transcription-polymerase-chain reaction (RT- 
PCR) procedures have become available for an assessment 
of the expression of each of the many globin genes. For 
instance, this technique has been applied to the two "y- 
(c3,- and A3,-) globin genes [2], the 13- and ~/-globin genes 
in [3-thalassemia (thai) [3-5], and has been used for the 
determination of the 13 A- and 13X-mRNA ratios in sickle 
cell trait [6] and in unstable hemoglobin (Hb) conditions 
and Hb E heterozygotes [7]. Similar data for a-chain 
variants have also been published [8]. In a previous publi- 
cation in this journal [9] we had the opportunity to analyze 
the relative ratios between the various mRNAs in reticu- 
locytes from persons with different forms of e~-thal. More 
recently, blood samples from as many as 40 Hb H patients 
became available for similar analyses that included the 
determination f the ratio between the eL 2- and ~x I-mRNAs, 
between the total c~-mRNA and 13-mRNA, and even be- 
tween the total c~-mRNA and ~-mRNA. The blood samples 
came from 34 patients with Hb H disease due to combina- 
tions of deletional c~-thal- 1determinants ( - - / )  and dele- 
tional eL-thai-2 determinants ( -  e~/) or a few nondeletional 
alleles (eft'a/), while in six patients the Hb H disease was 
caused by a homozygosity for one of two different non- 
deletional c~-thal-2 alleles. The data obtained in these 
analyses will be described here; they allow a detailed 
comparison between the expression of the c~ 2- and e~l- 
globin genes relative to that of the normal [3-globin gene, 
and an evaluation of the expression of the single ~-globin 
gene in these various deletional and nondeletional types of 
Hb H disease. Furthermore, some of the data, mainly the 
e~2/eL i- and o~/[3-mRNA ratios, can be correlated with the 
different phenotypes observed in the various patients and 
their determination might therefore have diagnostic signifi- 
cance. 
2. Materials and methods 
Blood samples from 40 patients with Hb H disease were 
collected in vacutainers with EDTA as anticoagulant. Those 
from Turkey and Northern Cyprus were transported by one 
of the authors or shipped by fast air mail service. The same 
procedure was followed for the samples from Hawaii and 
from Kuwait, while those collected from a few Vietnamese 
families living in South Carolina were transported in ice 
by car to the laboratory in Augusta, GA, USA. Informed 
consent was obtained. 
Hematological data were collected with an automated 
cell counter. Hb A 2 was quantified by microcolumn chro- 
matography [10] and the q-chain by reversed phase high 
performance liquid chromatography (HPLC) [11]. Quanti- 
tation of the unstable Hb H was not attempted because 
most had precipitated uring transport; however, data for 
~2 ~1 
CAP CAP 
A B A C 
CAP 
01 
CAP 
i i  G 
Sequences of Primers 
A 5' - GGCAAGAAGGTGGCCGACG - 3' 
B 5' - GGGAGGCCCATCGGGCAGGAGGAAC - 3' 
C 5' - GGGGGGAGGCCCAAGGGGCAAGAA- 3' 
D 5' - C AAGACTGAGAGGACCATCATrGTG - 3' 
E 5' - TCAGGACAGAGGATACGACCGATAG - 3' 
F 5' - GCTTTCCCCGCCACGAAGACC- 3' 
G 5' - GCGGCCACCCACCCACAGrr - 3' 
Location Relative to CAP Site 
+332 to +350 (a2;od) 
+768 to +744 (e.2) 
+778 to +755 (~1) 
+64 to +89 (~) 
+1547 to +1522 (~) 
+364 to +404 (01) 
+835 to +816 (01) 
Fragment Sizes (bp) 
Primers A+B DNA: 437 cDNA: 295 
Primers A+C 447 298 
Primers D+E 1481 403 
Primers F +G 452 344 
Fig. 1. The locations and sequences of the primers used in determining 
the ratios of the different mRNAs (c~2, a l ,  4, 01). The sizes of the 
amplification products are listed at the bottom. 
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most patients were available from earlier publications 
[9,12,13]. The same papers list the types of e~-thal-1 and 
deletional and nondeletional types of e~-thal-2 present in 
the 40 individuals. The presence or absence of a ~-globin 
gene deletion or triplication was evaluated in more than 
50% of all samples with gene mapping methodology as 
used in previous tudies [14]. 
RNA was isolated from 5-10 ml blood with the method 
of Chomczynski [15]. An RT-PCR procedure was used to 
determine the relative quantities of the c~2-, c~-, 13-, ~-, 
and 0vmRNAs. Details of the methods used for determin- 
ing the cx2/e~  and c~/[3 ratios have been given before 
[7-9]. The same RT product was used for the measure- 
ments of the ct/~, ct/0 n, and ~/0~ ratios. Five or 10 p.1 of 
this material served as template for 30 cycles of amplifica- 
tion. The method used the 'hot-start' PCR procedure to 
avoid primer dimerization. The 1 × PCR buffer contained 
2 mM MgCI 2, 0.2 mM of each dNTP, 50 pM of the primer 
A and 25 pM of the primers B, C, D and E, or F and G 
(Fig. 1), and 2.5 U of Taq DNA polymerase (Perkin Elmer 
Cetus, Norwalk, CT, USA) in a final volume of 100 p.l. 
Initial denaturation was for 5 rain at 99°C; the enzyme was 
added at 'hot-start'. The amplification profile for each 
cycle consisted of denaturation for 1 rain at 95°C, primer 
annealing for 1 rain at 64°C, and extension for 1 min 30 s 
at 72°C. The sequences of the primers and their locations 
are shown in Fig. 1. All primer pairs were selected in such 
a way that an intron is located between them; absence of a 
larger amplification product excludes the presence of con- 
taminating enomic DNA. PCR fragments were labeled by 
primer extension with ~/-32P-labeled primers A, D, and F 
during one cycle of PCR [3]. Three I~1 of the labeled PCR 
product were analyzed on a non-denaturing 6% polyacryl- 
amide gel and autoradiographed for 1, 3, and 6 h to 
evaluate the possible error due to limited film capacity. 
Relative amounts were determined by densitometric scan- 
ning with a Shimadzu (Kobe, Japan) CS 9000 densitom- 
eter. The average a/J3 ratio for normal adults (4.2-4.5) is 
higher than that of 2.52 reported by Lin et al. [16] who 
used different sets of primer and other experimental condi- 
tions, and similar to the 4.5 reported by Chami et al. [17] 
who also used different sets of primers but included a 
synthetic intemal standard. The average value for the 
c~2/an-mRNA ratio of 2.45-2.65 is comparable to that 
obtained by Molchanova et al. [8]. Differences in effi- 
ciency of translation of the c~- and [3-mRNAs will result in 
a balanced synthesis of a and [3-chains in the normal adult 
and will explain the marked differences in the relative 
levels of a- and [3-mRNAs [18]. 
3. Results 
Twelve of the 40 patients with Hb H disease, aged 2 to 
53 yr, were from Northern Cyprus, 17 from Ankara, 
Turkey, five from Kuwait, two from Hawaii, and four from 
Vietnamese families living in South Carolina. Twenty-one 
subjects had different types of deletional Hb H disease 
( -  - / -a ) ,  namely, four types of a-thal-1 (the MED-I 
type with a 17.5 kb deletion [19], the MED-II type with a 
26.5 kb deletion that includes the ~-globin gene [20], the 
- (~)20.5 type with the 20.5 kb deletion [21], the SEA 
Table 1 
The relative quantities of a2-,  a 1-, ~-, and !3-mRNA in reticulocytes from patients with Hb H disease a 
No. Genotype b V/ Hb (g/dD Hb A ~ c (%) 4 Chain d mRNA 
(% of c~ + 4) a~_/a E ratio a/ J3 ratio 4'  100/ (a  + 4) 
normals (acx/c~a) many 12-16 2.0-3.2 < 0.01 2.45-2.65 4.2-4.5 < 0.01 
1 - --MED-II/-- C~- 37 4 10.2--+0,9 0.9-+0.15 0.27--+0.19 0 1.02-+0.03 0.19;0.22;0.59 
2 -- --UED l / - -  C~-37 9 9.1 -+ 1.1 1.05-+0.15 0.31 -+0.28 0 1.01 -+0.12 1.6; 1.7; 1.8;2.2 
3 __ __MEDa/__ ~-42  1 9.7 1.05 0.20 0 1.01 1.1 
4 - - (a )20 .5 / - -  a -37 3 10.8-+ 1,8 1.0-+0.05 0.30-+0.08 0 1.02-+0.04 10.5; 17.6 
5 -- --SEA/-- C~-37 3 9.1-+0.6 0.95-+0.10 0.40;1.00 0 1.03-+0.04 15.7;8.6;5.1 
6 _ SEA/_  0/.-42 l 9.0 0.7 0.30 0 1.07 19.3 
7 _ MED- I / /~-5nt~ 6 9.5 -+ 0.6 0.55 -+ 0.05 0.22 -+ 0.01 0.15 -+ 0.09 0.71 -+ 0.07 0.29; 0.40; 0.41 
8 - (a)20.5/cx-  5ntc~ 1 9.7 0.8 0.13 0.10 0.59 0.24 
9 _ _MED-~/~PA 2~ 2 8.7;9.0 0.65;0.35 0.24;0.21 1.04;1.08 0.85; 0.89 0.88; 0.77 
10 --(a)20.5/c~PA-2a 2 8.7;7.2 0.6;0.9 0.43;0.45 1.09; 1.06 0.82; 0.79 0.44; 0.40 
11 _ _ SEA/aCSa 2 transfused 0.23; 0.18 0.53; 0.61 0.70; 0.43 
12 c~r'A-I a/~xPA-n cx 5 10.2-+1.9 1.8-+0.45 0 0.83-+0.14 1.15-+0.05 0 
13 a -  5ntc~/et- 5"tc~ 1 10.5 0.4 0 0.14 0.81 0 
Average data with SDs are listed for groups of three patients or more; an exception is the percentage of 4-mRNA which is listed for each individual 
patient ested. 
b Deletional ~-thal-I ( -  - ) are: MED-II = 26.5 kb deletion including the 4 gene; MED-I = 17.5 kb deletion; - (cx)20.5 = 20.5 kb deletion that includes 
the ~2 and the 5' end of ~1; SEA= 18 kb deletion. Deletional ~-thal-2 ( -c~)  are the 3.7 and 4.2 kb deletions. Nondeletional c~-thal are: 
c~-5'ltcx = deletion of TGAGG at the donor splice site of the IVS-I; c~PA-U~x and efl'A-2~ are poly(A) mutations or AATAAA --* AATAAG and AATGAA, 
respectively; CS = Hb Constant Spring or a terminating codon (~2 142, TAA ~ CAA). 
c By microcolumn chromatography [10]. 
d By reversed phase HPLC [11]. 
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type with an ~ 18 kb deletion that includes the 01-globin 
gene [19]) and one of the two common ~-thal-2 types (the 
3.7 or the 4.2 kb deletion). Thirteen had Hb H disease due 
to a combination of one of the four listed ~x-thal-1 dele- 
tions with a nondeletional type of cx-thal-2, namely the 5 
nucleotide (nt) deletion at the donor splicing site of the 
first intervening sequence (IVS-I), the poly(A) mutation 
AATAAA -~ AATGAA, and the terminating codon muta- 
tion Hb Constant Spring (Hb CS) (for references, see 
Higgs and Weatherall [ 1 ]). The six remaining patients were 
either homozygous for another poly(A) mutation 
(AATAAA ~ AATAAG [22]) or for the 5 nt deletion. 
Table 1 provides some details that include the total Hb 
levels, the Hb A 2 values, and the levels of the C-chain, 
determined by reversed phase HPLC. Previous analyses 
[12] had confirmed the fact that Hb H levels are consider- 
ably higher in patients with nondeletional Hb H disease 
( - - / c~vc~)  than with the deletional type ( - - / -~) .  
Differences were also apparent in the levels of Hb A 2 that 
were significantly lower in the subjects with the nondele- 
tional Hb H disease ( - - /~Vcx ; average 0.60 with a range 
of 0.35-0.9) than in those with the deletional Hb H disease 
( / c~; average 0.98 with a range of 0.7-1.3). The 
levels of C-chain were low and about the same in both 
groups (0.34% with a range of 0.10-1.12 for - - / - cx ,  
and 0.25 with a range of 0.13-0.45 for - --/c~T~). No 
C-chain was detected in the six patients with a homozygos- 
ity for a nondeletional -thai determinant. 
A summary of the mRNA analysis is provided in Table 
1, while Fig. 2 illustrates ome of the separations that have 
been obtained. As expected, the ~ 2/o~ ratio was zero for 
all Hb H patients with deletion of three ot-globin genes 
( -  - / -  cx); their reticulocytes contained c~ I-mRNA only 
(the mRNA of the ~2~1 hybrid gene due to the 3.7 kb 
deletion is determined as an ~xn-mRNA [8]). Extremely 
low values for the ot2/o~j-mRNA ratio were observed in 
patients with --/c~fet in which the T is the 5 nt deletion at 
the IVS-I donor splicing site or the TAA ~ CAA terminat- 
ing codon mutation. The values were considerably higher 
at ~ 1.0 for patients in whom T is a poly(A) mutation. 
Similar differences were seen between the five patients 
with a homozygosity for a poly(A) mutation (average 0.83) 
and the one with a homozygosity for the 5 nt deletion 
(0.14). 
The c~/13-mRNA ratio averaged ~ 1.0 for the patients 
with - - / - c~, a decrease of nearly 80% of the normal 
ratio (4.2-4.5). These values were lower (~ 0.7) in the 
patients with - -/oLVo~; this decrease was independent of 
the type of nondeletional oL-thal. The ratios were slightly 
higher for the five subjects with the homozygosity for a 
poly(A) mutation (average 1.15) but not for the patient 
with the homozygosity for the 5 nt deletion (0.81). 
Extremely low quantities of C-mRNA appear to be 
present in reticulocytes of normal adults, and accurate 
ratios between this embryonic globin gene transcript and 
that of the o~-globin genes could not be established. In- 
creased ratios were found for all patients with Hb H 
disease except for the six with a homozygosity for a 
nondeletional a-thal (Table 1). In most instances the C- 
mRNA level was below 1.0%, but significant increases 
were seen in the subjects with -__MED-~/__ 0/.-3.7 (aver- 
age 1.83%) and in the patients with the -(e¢)20.5/ or 
A B 
12345 6789 
o~ (295;298) 
[3 (192) 
(403) 
o~ (295;298) 
C 
9 
el (344) 
o. (295;298) 
13 
1011 12 13 14 15 16 17 
(403) 
el (344) 
Fig. 2. Separation of the RT-PCR products on a 6% polyacrylamide gel. A. The 0~/13 ratio. Lanes 2,3,4,5: Homozygous poly(A) patients or 
ar'A-la/aPA-na; lane 1: Normal control. B. The a /~ ratio. Lanes 6 and 7: Same sample with - __MED-I/__ C~-37; lane 8: Sample with - (~)20 .5 / -  a -37;  
lane 9: Sample with - -MED-V/a-Snta. C. The cx/01 ratio. Lanes 10 and 11: Same sample with - -MED4/_a  37; lanes 12 and 13: Two additional 
samples with - -MED-[/__ a -37  The larger fraction remains unidentified. D. The ~/01 ratio. Lane 14: Sample with - -SEA/aCSa; lane 15: Normal 
control; lanes 16 and 17: Same sample with - -MEDal/Ot-5,to~. The numbers behind the symbols indicate sizes of the fragments. 
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- - -SEA/a - tha i -1  combined with a deletional a-thal-2 
(either -3 .7  or -4 .2  kb) but not with a nondeletional 
a-thai-2 (either a poly(A) mutation, the 5 nt deletion, or 
the Hb CS terminating codon mutation). These differences 
were highly significant, varying from 5.1-19.3% in the 
patients with the deletional Hb H disease [ - _SEA/ / _a  
or - - (e~)20.5/ - -a]  and 0.25-0.7 in those with the non- 
deletional Hb H disease [---SEA/cxCSa, - - (a)20.5 /  
a-5nta, or -(a)20.5//aPA-2a]. None of the patients had a 
~-globin gene deletion or triplication. 
The 01-mRNA was present in all samples that were 
tested and its quantity varied considerably (Fig. 2). Unfor- 
tunately, an unexplained larger fragment appeared when 
the o~- and 01-cDNA were amplified simultaneously, thus 
preventing any quantitative measurements. This was not 
the case for the co-amplification of the 4- and 01-cDNAs 
(Fig. 2D). Considerably more 01 transcript was present 
than ~ transcript except for the patients with the SEA 
a-thal-1 deletion that includes the 01 gene in addition to 
the a 2- and a l-globin genes [1 ]. 
4. D iscuss ion  
Thirty-four of our 40 patients with Hb H disease had 
combinations of one of four a-thai-1 deletions with either 
one of two deletional or one of three nondeletional deter- 
minants. The sizes and locations of the six deletions are 
shown in Fig. 3; the nondeletional a-thal-2 alleles are of 
interest because one concerns a 5 nt deletion at the donor 
splicing site of the IVS-I that affects splicing of this intron, 
a second, i.e. Hb CS with a TAA--* CAA mutation at 
codon 142, modifies the terminating codon, while the 
third, i.e. an AATAAA ~ AATAAG mutation of the 
poly(A) site, affects the polyadenylation f the a 2-mRNA. 
This considerable diversity makes an evaluation of the 
relative levels of the a 2- and a I-mRNAs in the total a- 
and [3-mRNAs worthwhile, as it allows a comparison 
between the expression of the genes of the a cistron, and 
may explain some of the clinical differences that have 
been observed between these patients. Earlier communica- 
tions from this laboratory [8,9] have reported similar data, 
however, mainly for simple heterozygotes for some of 
these determinants. 
Okb lOkb 20kb 30kb 
I I I I 
~ H V R  ~1 ~o.2 ~/etl m2 o,1 01 3'~VR 
__  F~F~ ~ m m m m  . 
-(c020.5 
- -  MED-1 
- -  MED-2 
- -  SEA 
-(-3.7kb) 
-(-4.2kb) 
Fig. 3. The four ~-thal-1 and two c~-thal-2 deletions present in most of 
our patients with Hb H disease. 
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Fig. 4. The a2 /a l -  and c~/I3-mRNA ratios for the individual Hb H 
patients (total number is 40). The numbers at the top of the figure refer to 
the genotypes listed in Table 1. 
The mRNA data, which form the basis of the summary 
given in Table 1, are plotted individually in Fig. 4. Patients 
with deletional types of Hb H disease ( - - / - a )  have 
no ~ 2-mRNA and an a/13-mRNA ratio of approximately 
one. This value is remarkably similar for all six types; the 
one remaining a L-globin gene transcribes one-fourth of the 
level of a-mRNA in normal adults. Translation must be 
most efficient in these patients who are able to maintain 
8-10 g/100 ml of a-chain-containing Hbs in their periph- 
eral blood. The data for the 13 patients with a nondele- 
tional type of Hb H disease ( - - /aTa)  are different. 
According to the a 2 /a  I-mRNA ratio the subjects with the 
5 nt deletion at the donor splicing site of IVS-I 
(-- --//a-5nta) must have a small amount of a2-mRNA 
in their reticulocytes, as does the one patient with a 
homozygosity for this allele. Apparently the TGAGG dele- 
tion at the donor site AGt  G TGAGGCTCCC 
AG t GCTCCC greatly decreases but does not completely 
eliminate the splicing. The a2 /a  I ratio in the two sub- 
jects with the Hb CS mutation ( -  - /aCSc~) is also low at 
about 0.2; earlier studies [23] have suggested that this type 
of mRNA is elongated and uses the TAA sequence in the 
normal AATAAA poly(A) sequence as terminating codon 
and the cryptic poly(A) sequence at 1048 bp past the 
terminating codon 142 as its poly(A) site. A similar situa- 
tion exists for the four patients with the poly(A) mutation 
( -  -/aPA-2c~). The much larger relative quantity of a 2- 
mRNA in these four subjects, as well as in the five Hb H 
patients with a homozygosity for the PA-1 mutation 
(AATAA A ~ AATAAG) resulting in high a2 /a  I ratios 
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of 0.65-1.1, is entirely of the elongated type with a normal 
terminating codon and an abnormal polyadenylation se- 
quence [23]. The low 0-/[3-mRNA ratio in the 13 patients 
with - -/0-T0- Hb H disease suggests that the mutation 
in the 0- 2-globin gene indirectly affects the transcription of 
the 0-1-globin gene; the mechanism remains unknown. 
This oL/[3-mRNA ratio (average 0.7) is significantly lower 
(P = < 0.01) than that observed in patients with deletional 
Hb H disease ( -  - / -0 - ;  average value ~ 1.0) which is 
in accordance with the more serious clinical condition of 
these patients, their lower Hb level, their higher percentage 
of Hb H. and their lower level of Hb A2 (Table 1). 
The determination of the 0-2/0-1- and ~/13-mRNA 
ratios is done from one amplification reaction and can be 
completed within 2-3 days for samples from several pa- 
tients simultaneously. The differences in these two ratios 
are highly diagnostic and the methodology can be used to 
distinguish between deletional and nondeletional types of 
Hb H disease. 
The presence of ~-globin chains in red cells from 
newborn babies and adults has been evaluated with sensi- 
tive immunoassays [24-26] and by reversed phase HPLC 
methodology [11,20,26]. Red cells from normal babies 
often have a minute quantity of ~ which increases with the 
presence of 0--globin gene deficiencies. Notable amounts 
are found in babies and adults with the SEA 0--thal-I 
deletion and Chui et al. [24] suggest that its level can serve 
as a marker for this oL-thal-1 haplotype. We have detected 
minute quantities (0.5% of total 0- + ~) in all patients with 
Hb H disease xcept for the six who were homozygous for 
one of two nondeletional 0--thai determinants (Table 1). 
The highest level was seen in the three patients with the 
__ __SEA//_ Ot--3.7 or 4.2 type of Hb H disease. 
Albitar et al. [27] and Tang et al. [28] used a PCR 
technique to evaluate the presence of 01-, ~-, and e-globin 
mRNAs and indeed observed minute quantities of these 
mRNAs in reticulocytes of normal adults. We have made a 
similar observation; however, an acceptable ~/0--mRNA 
ratio was often not obtained with our technique. Increased 
levels of ~-mRNA were observed in the reticulocytes of all 
our patients with Hb H disease except those with a ho- 
mozygosity for a nondeletional 0--thai-2 determinant (Ta- 
ble 1). The calculated ratio (%~ of 0- + ~) was the lowest 
in the reticulocytes of the patients with the nondeletional 
Hb H disease ( -  - /o~va)  with an average of 0.5% and no 
distinct differences between the types of 0--thal determi- 
nants. The values for the patients with deletional Hb H 
disease ( - - / -a )  are quite different. Except for those 
with the -__MED-II//__ C¢_-3.7 condition, where low levels 
were present because the MED-II deletion includes the 
~-globin gene (Fig. 3), the values were increased to ~ 1.7% 
for - S~ED-I//_ ~x 3.7 or-42, to 14.0% for --(0-)20.5/-- 
O¢_ 3.7 and to 12.2% for -SEA/ / __  0--3.7or 4.2 (Table 1). 
These results are difficult to explain but may suggest hat 
certain sequences are important for the suppression of the 
~-globin gene expression. Suggested areas are sequences 
between the ~2- and ~-globin genes (high ~-mRNA in Hb 
H patients with the - (0 - )20 .5 / -0 .  -3.7 type) and those 
involving the 01-globin gene (high ~-mRNA in Hb H 
patients with the _ SEA/_ot-3.7 or-4.2 genotype). 
Translation of this ~-mRNA appears not to be efficient 
because of the low levels of E-chains observed in the 
reticulocytes of these patients. Finally, the presence of the 
3.7 or 4.2 kb deletion on the opposite chromosome must 
play a major role, and it may well be that the ~-globin 
gene of this chromosome contributes the major portion of 
the elevated level of ~-mRNA. Why else would the ~- 
mRNA level be below 1% in Hb H patients with the same 
deletional c~-thal- 1 [ -  - SEA/; _ (0020.5/] but in combi- 
nation with a nondeletional o~-thal determinant! 
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